Induction of Futile DNA Repair Processes by Bifunctional Intercalators
Ditercalinium is a DNA bifunctional intercalator endowed with antitumor properties. It binds to DNA with high affinity, forming a noncovalent and reversible complex. NMR studies of a ditercalinium oligonucleotide complex have revealed that, in the DNA complex, the linking chain of ditercalinium is located in the large groove of the DNA double helix, and that a bending of the double helix is induced toward the small groove.
It was found that ditercalinium and its antitumor analogues, but not its monomeric derivative, elicit a specific toxicity on polA strains of E. coli. This toxicity is suppressed by the uvrA mutation. In polA strains, ditercalinium induces SOS functions, although no immediate DNA synthesis arrest is observed. In the thermosensitive ligase deficient strain lig7, single-strand breaks accumulate at non-permissive temperature. It is proposed that the structural alteration induced in DNA after ditercalinium binding is recognized by the UVR repair process in E. coli. Because of the noncovalent nature of the DNA-ditercalinium complex, this structural alteration acts as a mock lesion or a lure which triggers a futile and abortive repair process.
In mammalian cells, ditercalinium causes a delayed cytotoxicity. Cells treated with ditercalinium die only 5 to 6 generations after drug exposure. Mitochondrial DNA is rapidly lost, and no damage is observed on nuclear DNA. It is hypothesized that the loss of mitochondrial DNA is related to a malfunctioning of a DNA repair process. DNA structural alterations, caused by agents forming non-covalent and reversible complexes with DNA, appear as a new type of lesion which could, in some conditions, completely fool the DNA repair machinery, and which would then become deleterious for the cells.
KeywordsToxicity Sucrose Leukemia Respiration Electrophoresis
Unable to display preview. Download preview PDF.
- Esnault, C., Roques, B. P., Jacquemin-Sablon, A., and Le Pecq, J.-B., 1984, Effectg of new antitumor bifunctional intercalators derived from 7H-pyridocarbazole on sensitive and resistant L1210 cells, Cancer Res., 44:4335.Google Scholar
- Fellous, R., Coulaud, D., El Abed, I., Roques, B. P., Le Pecq, J.-B., Delain, E., and Gouyette, A., 1988, In vivo and in vitro cytoplasmic accumulation of Ditercalinium in rat hepatocytes induces mitochondrial damages, Cancer Res. In press.Google Scholar
- Garbay-Jaureguiberry, C., Laugaâ, P., Delepierre, M., Laalami, S., Muzard, G., Le Pecq, J.-B., and Roques, B. P., 1987, DNA bis-intercalators as new antitumor agents: modulation of the anti-tumour activity by the linking chain rigidity in the Ditercalinium series, Anti-Cancer Drug Design, 1:323.PubMedGoogle Scholar
- Lambert, B., and Le Pecq, J.-B., 1982, Isolement et caract-érisation de souches d’ E. coli sensibles à des toxiques hydrophiles et/ou charges, C. R. Hebd. Seances, Acad. Sci., Ser. C., 294:447.Google Scholar
- Laugâa, Ph., Markovits, J., Delbarre, A., Le Pecq, J.-B., and Roques, B. P., 1985, DNA tris-intercalation: First acridine trimer with DNA affinity in the range of DNA regulatory proteins. Kinetic studies. Biochemistry, 24:5567.Google Scholar
- Segal-Bendirdjian, E., Coulaud, D., Roques, B. P., and Le Pecq, J.-B., 1988, Selective loss of mitochondrial DNA after treatment of cells with Ditercalinium (NSC 335153), an antitumor bis-intercalating agent, Cancer Res., 40: 4982.Google Scholar
- Traganos, F., Bueti, C., Melamed, M. R., and Darzynkiewicz, Z., 1987, Cytokinetic effects of bifunctional antitumor intercalator Ditercalinium on Friend erythroleukemia cells, Leukemia (Baltimore), 1:411.Google Scholar